MTLS Materialise N.V.
USTechnologyAs of 2026-07-09 16:00
Why MTLS matters now
Materialise N.V. (MTLS) is a US stock in Technology. The latest InvestLog snapshot shows $6.93 with +0.73% on the session and $405.8M in market capitalization; recent performance reads 1-month +20.68% and YTD +20.90%.
The latest financial table shown here is Q1 2026, with revenue of $66.3M, net income of $1.8M, and EPS of $0.03. Investors can compare that operating picture with valuation signals such as P/E 37.07 and FCF yield 1.8%.
The latest indexable market news headline is "Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutions" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $10.00. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
37.07
PEG
—
P/B
1.35
P/S
1.29
EV/EBITDA
8.82
DCF Value
$4.78
FCF Yield
1.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
57.6%
Operating Margin
3.9%
Net Margin
3.8%
ROE
4.1%
ROA
2.4%
ROIC
3.1%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $66.3M | $1.8M | $0.03 |
| Q4 2025 | $70.2M | $6.2M | $0.11 |
| FY 2025 | $257.1M | $7.4M | $0.13 |
| Q3 2025 | $67.5M | $1.9M | $0.03 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$10.00
Target (Median)
$10.00
Target Range
$10.00 - $10.00
Related Stocks
Latest News
Company Info
Sector
Technology
Industry
Software - Application
Country
BE
Exchange
—
Beta
1.35
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.